Neoadjuvan kemoterapinin olası benign meme lezyonları üzerindeki etkilerinin MRG ile değerlendirilmesi: İki olgu sunumu
Author:
Affiliation:
1. Department of Radiology, Ege University Faculty of Medicine, Izmir, Turkiye
2. Department of General Surgery, Ege University Faculty of Medicine, Izmir, Turkiye
Abstract
Publisher
Ege Journal of Medicine
Subject
General Medicine
Reference10 articles.
1. Panigrahi B, Harvey SC, Mullen LA, et al. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI. Clin Breast Cancer. 2019 Feb; 19 (1): e152-e159.
2. Schott AF, Roubidoux MA, Helvie MA, et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat. 2005 Aug; 92 (3): 231-8.
3. Symmans WF, Peintinger F, Hatzis C, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007 Oct 1; 25 (28): 4414-22.
4. Ah-See ML, Makris A, Taylor NJ, et al. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res. 2008 Oct 15; 14 (20): 6580-9.
5. Carder P. Typing breast cancer following primary chemotherapy. Histopathology. 1999 Dec; 35 (6): 584-5.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3